After univariate and multivariate cox analysis of key clinical and molecular factors, we found that CCNB2 expression (P‐value < 0.001, HR = 1.598/1.256), and CDC20 expression (P‐value < 0.001, HR = 1.606/1.246), and MYBL2 expression (P‐value < 0.001, HR = 1.570/1.258) were independent prognostic factors for gliomas in the CGGA dataset (Figure 10B‐C, and Figures S5B,C and S6B,C). Here, CCNB2 is linked to central nervous system cancer.